However, in lymphoma cells, miR‐155‐5p could positively regulate the transcriptional activity of PD‐L1 and inhibit CD8+ T cell function via the PD1/PD‐L1 pathway to enhance the immune tolerance of tumor cells [12]. This evidence concerns the gene CD274 and lymphoma.